Department of Orthopedics, Changhai Hospital, Second Military Medical University, Shanghai, China.
Graduate Management Unit, Second Military Medical University, Shanghai, China.
Stem Cell Res Ther. 2018 Feb 7;9(1):32. doi: 10.1186/s13287-018-0785-5.
Several studies have focused on umbilical cord-derived mesenchymal stem cells (UC-MSCs) due to their potential therapeutic effects in a cluster of diseases. However, there has been no bibliometric analysis evaluating the evolution in UC-MSC research. Therefore, this study aimed to assess scientific activity regarding UC-MSC research. Publications on UC-MSCs were retrieved from the Science Citation Index-Expanded (SCI-E) of the Web of Science (WoS) from 1975 to 2017. Statistical analyses were performed using Excel, GraphPad Prism 5, and VOSviewer software. Comparative analyses were employed to assess contributions between different countries, institutes, and researchers. With 21.26 citations per paper, 1206 papers cited 25,517 times were included. Mainland China contributed the most with 558 papers, with the most citations (6858 times) and the highest H-index (43). South Korea ranked first for number of papers per million people and per trillion gross domestic product (GDP). Keywords were stratified into two clusters by VOSviewer software: cluster 1, "treatments and effects"; and cluster 2, "characteristics". The average appearing years (AAY) of keywords in cluster 1 was more recent than that in cluster 2. For promising hotspots, "TNF-α" showed the latest AAY at 2014.09, followed by "migration", "angiogenesis", and "apoptosis". We conclude that the number of publications has been continuously growing dramatically since 2002 and that mainland China and South Korea are the most productive regions. The focus gradually shifts from "characteristics" to "treatments and effects". Attention should be drawn to the latest hotspots, such as "TNF-α", "migration", "angiogenesis", and "apoptosis". Furthermore, funding agencies might increase investments in exploring the therapeutic potential of UC-MSCs.
多项研究聚焦于脐带间充质干细胞(UC-MSCs),因为它们在一系列疾病中具有潜在的治疗效果。然而,目前还没有对 UC-MSC 研究进展进行文献计量分析的研究。因此,本研究旨在评估 UC-MSC 研究的科学活动。从 Web of Science(WoS)的科学引文索引扩展版(SCI-E)中检索到 1975 年至 2017 年期间有关 UC-MSCs 的出版物。使用 Excel、GraphPad Prism 5 和 VOSviewer 软件进行统计分析。比较分析用于评估不同国家、机构和研究人员的贡献。每篇论文的平均引用率为 21.26,共引用了 1206 篇论文 25517 次。中国大陆的论文发表量最多,有 558 篇论文,被引次数最多(6858 次),H 指数最高(43)。韩国的人均论文发表量和每百万人口人均 GDP 论文发表量均排名第一。VOSviewer 软件将关键词分为两个聚类:聚类 1,“治疗和效果”;聚类 2,“特征”。聚类 1 中关键词的平均出现年份(AAY)比聚类 2 中的关键词更接近现在。对于有前途的热点,“TNF-α”的 AAY 最晚,为 2014.09,其次是“迁移”、“血管生成”和“凋亡”。我们得出结论,自 2002 年以来,出版物的数量一直在持续大幅增长,中国大陆和韩国是最具生产力的地区。研究重点逐渐从“特征”转移到“治疗和效果”。应关注最新的热点,如“TNF-α”、“迁移”、“血管生成”和“凋亡”。此外,资助机构可能会增加对探索 UC-MSCs 治疗潜力的投资。
Biomed Res Int. 2018-5-27
BMJ Open. 2017-10-22
Int Wound J. 2023-10
Arch Osteoporos. 2021-4-17
Front Oncol. 2022-9-29
Front Med (Lausanne). 2024-11-20
J Inflamm Res. 2024-3-6
Environ Sci Pollut Res Int. 2024-3
Orphanet J Rare Dis. 2017-1-18